In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Editorial - July 2023

ESC Working Group on Cardiovascular Regenerative & Reparative Medicine

The ESC 2023 Congress promises rich content for insights and networking opportunities in the ever-evolving field of regenerative medicine.

For those interested in becoming a member of the Working Group, we encourage you to approach any of the nucleus members during the congress for more information. They will be more than happy to guide you through the process and discuss the benefits of joining this dynamic and influential group. This is a unique opportunity to learn, engage and contribute to the field of regenerative medicine.

The Working Group CARE recommends an insightful selection of sessions that reflect the current landscape in regenerative medicine, spanning both basic research and translational aspects. From exploring cellular communications at single-cell resolution in cardiovascular diseases to understanding the potential of stem cell-derived cardiomyocytes, from exploring the potential of RNA therapeutics to engaging with the latest research in cardiac regeneration, these sessions offer a comprehensive overview of the field.

  1. The symposium on "Cellular Communications at Single-Cell Resolution in Cardiovascular Diseases" (25 August at 11:15) offers a unique opportunity to understand the complex interplay between different cell types in the heart, a crucial aspect of regenerative medicine.
  2. The "Advances in Science" session on "Novel Mechanistic Insights into Arrhythmias" (25 August at 8:30) will provide insights into the latest research on stem cell-derived cardiomyocytes and their engraftment without arrhythmia.
  3. The symposium on "RNA Therapeutics for Cardiovascular Disease" (26 August at 14:00) will explore the promising field of RNA therapeutics, which has the potential to revolutionize the treatment of cardiovascular diseases.
  4. Poster sessions will be a fantastic opportunity to engage with researchers. Particularly recommended for in-depth discussions and the chance to form collaborations are the sessions on "Cardiac Regeneration" (25 August at 12:15) and "Pathophysiology of Heart Failure: Basic Mechanisms" (26 August at 10:15).
  5. Finally, the session on "Circulation: The Full Spectrum" (25 August at 11:15) will provide a comprehensive overview of the latest research and advancements in regenerative medicine.

PD Dr Marie-Noelle Giraud, Communication coordinator

Prof Giulio Pompilio, Chairperson

On behalf of the ESC Working Group on Cardiovascular Regenerative and Reparative Medicine